The patients' data examined in this study were from the collective of the 5-FU/FA versus 5-FU/FA/irinotecan
phase III FOGT-4 trial. Tumor tissues were stained by immunohistochemistry for VEGF-C, VEGF-D, VEGFR-3, Hif-1 α, PTEN,
AREG and EREG expression and evaluated by two independent, blinded investigators.
Survival analyses were calculated for all patients receiving adjuvant chemotherapy in relation to expression of all
makers above.
The patients' data examined in this study were from the collective of the 5-FU/FA versus 5-FU/FA/irinotecanphase III FOGT-4 trial. Tumor tissues were stained by immunohistochemistry for VEGF-C, VEGF-D, VEGFR-3, Hif-1 α, PTEN,AREG and EREG expression and evaluated by two independent, blinded investigators.Survival analyses were calculated for all patients receiving adjuvant chemotherapy in relation to expression of allmakers above.
การแปล กรุณารอสักครู่..